In recent years those in the scientific community concerned with environmental and public health have been called upon to consider two categories of previously unsuspected materials characterized by wide distribution and long persistence in the environment: mercury, especially organic mercury, and the chlorinated diphenyls (PCBs). To a significant extent this conference presents again the same types of problems previously posed by mercurials and PCBs. We should note, however, one important difference which suggests that fundamental progress has been made: previously, with respect to mercury and PCBs, serious epidemics of overt disease had arisen which stimulated an intensive search for the respective etiologies; we are today in the clearly preferable position of having an etiology which is searching for a disease.
The matter of phthalic acid esters (PAEs) in the environment has come to our attention through the efforts of inquiring scientists who noted the persistent appearance of an unknown substance in dissimilar media. While we can take no credit from these conscientious observers, it is here in a sense distressing to note that for many years it had been known that plasticizers are extractable from blood bags and tubing and yet this information was not fully exploited or disseminated to parties who might have had an interest in the subject.
We have heard that the annual production of the various phthalic diesters approximates The optimal plasticizer would obviously be one which does not out-migrate from PVC, and no one can quibble with the position that plasticizers in banked blood are not desirable. The extent of their nondesirability is, of course, a function of their biological properties, which are as yet incompletely defined. While appropriate studies merit prompt initiation, we cannot afford to be stampeded into an unsupported demand for unfamiliar alternative plasticizers or polymer systems. All substitutes will invariably require their own specific toxicological appraisal. Moreover, the suitability of so-called nontoxic polymer systems to blood banking technology will require special scrutiny. The physical integrity of the blood bag and the high degree of reliability of present fabrication technology should not be sacrificed for the supposed advantages of other polymers or plasticizers.
On the other hand, it is clear that industry is called upon to create more permanent plasticizers and to consider other unplasticized polymers and multipolymer laminates which are suitable, especially to blood banking. The argument that an intrinsically more suitable polymer system is not adaptable to production technology needs to be critically examined. While these polymer systems may not be suitable to well established PVC fabrication technology, it is not unreasonable to believe that parallel technologies for fabricating other polymers may be developed. We are aware that costs of materials and fabrication are relevant. The position that cost is not a factor when health is concerned is clearly an oversimplication and possibly simple demagoguery.
Data derived from human experience have been reported. Diethylhexyl phthalate (DEHP) associated with the transfusion of bagged blood into patients is detectable in lung, liver, and spleen. Limited studies of phthalate metabolism following transfusion have been reported. The extent to which PAEs or their metabolites occur in normal human populations remains to be defined. While it is invariably painful for the analyst to retract data previously published, we may find that this move is necessary when unrecognized sources of laboratory or hospital contamination become known or when misinterpreted peaks or chromatographic spots become correctly identified.
Human oral toxicity cannot be judged on the basis of three single doses of 5 or 10 ml of DEHP taken by volunteers or in error. It is apparent that PAEs from food packaging materials do enter the body in conjunction with our normal diet. With a presumed no-effect chronic exposure level of 60 mg/kg in animals, our assumption that man's metabolic capacity is adequate to deal with the current dietary load of PAEs would appear to have support. Orally administered DEHP is metabolized more rapidly than it is absorbed by several animal models. The experiments performed in this area, however, are not definitive, and "no-effect" is largely dependent upon the precise effects for which one is searching. While we need not be critical of the standard approach, we naturally wonder if a more detailed inquiry into human toxicology might be warranted. We further wonder at the extent to which one can generalize to the entire class of PAEs from studies performed upon one or two compounds.
Along the line of human investigations, data based upon industrial hygiene and occupational health studies are conspicuously absent. The Russian report of polyneuritis in workers exposed to phthalate esters requires confirmation. Although PAEs are manufactured in closed systems, there are undoubtedly significant populations working in ester synthesis and polymer compounding which are exposed to measurable atmospheric concentrations of PAEs.
There is evidence that aquatic organisms both concentrate PAEs and demonstrate higher levels of vulnerability than do warmblooded animals. Disturbances of reproduction and growth of aquatic species have been demonstrated in water containing PAEs at concentrations approximating 3 ,ug/l. It is entirely possible, therefore, that current levels of PAEs in certain natural bodies of water are sufficiently high to be injurious to aquatic life. These observations redirect out attention to the suggested biodegradability of PAEs.
It would be our unanimous judgment that this conference has been conducted under most inviting circumstances. For this hospitality and attention to arrangements and logistics we are much indebted to Dr. Rall, his colleagues, and the U.S. taxpayer. *U.S. GOVERNMENT PRINTING OFFICE: 1973-735-501/2 Environmental Health Perspectives
